世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037291

片頭痛治療薬の世界市場(2024-2028)

TechNavio

Global Migraine Drugs Market 2024-2028

発刊日 2023/11/23

言語英語

体裁PDF/168ページ

ライセンス/価格168ページ

0000037291

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

片頭痛治療薬市場は2022年から2027年にかけて11億3,992万米ドル、予測期間中のCAGRは6.05%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。片頭痛患者の増加、再生医療の登場、臨床効果の高い新クラスの片頭痛治療薬の導入などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ エンドユーザー別
      ◇ 病院
      ◇ 小売り
      ◇ オンライン
    ➣ タイプ別
      ◇ 予防
      ◇ 中止
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域(ROW)

本調査では、片頭痛治療薬の進歩の高まりが、今後数年間の片頭痛治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、片頭痛治療啓発プログラムの増加や薬剤の改良が市場の大きな需要につながると考えられます。

片頭痛治療薬市場に関するレポートは、次の分野をカバーしています。

  • 片頭痛治療薬市場の規模
  • 片頭痛治療薬市場の予測
  • 片頭痛治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ AbbVie Inc.
    ➣ Amgen Inc.
    ➣ Amneal Pharmaceuticals Inc.
    ➣ AstraZeneca
    ➣ Bausch Health Co. Inc.
    ➣ Bayer AG
    ➣ Dr Reddys Laboratories Ltd.
    ➣ Eli Lilly and Co.
    ➣ Endo International Plc
    ➣ GlaxoSmithKline Plc
    ➣ H Lundbeck AS
    ➣ Johnson and Johnson Services Inc.
    ➣ Merck KGaA, Neurelis Inc.
    ➣ 大塚ホールディングス(Otsuka Holdings Co. Ltd.)
    ➣ Pfizer Inc.
    ➣ Sanofi
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Winston Pharmaceuticals Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global migraine drugs market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global migraine drugs market 2018 - 2022 ($ billion)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Retail - Market size and forecast 2023-2028
Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
6.5 Online - Market size and forecast 2023-2028
Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ billion)
Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2023-2028 (%)
Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Preventive - Market size and forecast 2023-2028
Exhibit 52: Chart on Preventive - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Preventive - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Preventive - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Preventive - Year-over-year growth 2023-2028 (%)
7.4 Abortive - Market size and forecast 2023-2028
Exhibit 56: Chart on Abortive - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Abortive - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Abortive - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Abortive - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 60: Market opportunity by Type ($ billion)
Exhibit 61: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 115: Amgen Inc. - Overview
Exhibit 116: Amgen Inc. - Product / Service
Exhibit 117: Amgen Inc. - Key offerings
12.5 Amneal Pharmaceuticals Inc.
Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
12.6 AstraZeneca Plc
Exhibit 123: AstraZeneca Plc - Overview
Exhibit 124: AstraZeneca Plc - Product / Service
Exhibit 125: AstraZeneca Plc - Key news
Exhibit 126: AstraZeneca Plc - Key offerings
12.7 Eli Lilly and Co.
Exhibit 127: Eli Lilly and Co. - Overview
Exhibit 128: Eli Lilly and Co. - Product / Service
Exhibit 129: Eli Lilly and Co. - Key news
Exhibit 130: Eli Lilly and Co. - Key offerings
12.8 Endo International Plc
Exhibit 131: Endo International Plc - Overview
Exhibit 132: Endo International Plc - Business segments
Exhibit 133: Endo International Plc - Key news
Exhibit 134: Endo International Plc - Key offerings
Exhibit 135: Endo International Plc - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 136: GlaxoSmithKline Plc - Overview
Exhibit 137: GlaxoSmithKline Plc - Business segments
Exhibit 138: GlaxoSmithKline Plc - Key news
Exhibit 139: GlaxoSmithKline Plc - Key offerings
Exhibit 140: GlaxoSmithKline Plc - Segment focus
12.10 H Lundbeck AS
Exhibit 141: H Lundbeck AS - Overview
Exhibit 142: H Lundbeck AS - Product / Service
Exhibit 143: H Lundbeck AS - Key offerings
12.11 Johnson and Johnson
Exhibit 144: Johnson and Johnson - Overview
Exhibit 145: Johnson and Johnson - Business segments
Exhibit 146: Johnson and Johnson - Key news
Exhibit 147: Johnson and Johnson - Key offerings
Exhibit 148: Johnson and Johnson - Segment focus
12.12 Merck and Co. Inc.
Exhibit 149: Merck and Co. Inc. - Overview
Exhibit 150: Merck and Co. Inc. - Business segments
Exhibit 151: Merck and Co. Inc. - Key news
Exhibit 152: Merck and Co. Inc. - Key offerings
Exhibit 153: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 154: Novartis AG - Overview
Exhibit 155: Novartis AG - Business segments
Exhibit 156: Novartis AG - Key offerings
Exhibit 157: Novartis AG - Segment focus
12.14 Otsuka Holdings Co. Ltd.
Exhibit 158: Otsuka Holdings Co. Ltd. - Overview
Exhibit 159: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 160: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 161: Otsuka Holdings Co. Ltd. - Segment focus
12.15 Pfizer Inc.
Exhibit 162: Pfizer Inc. - Overview
Exhibit 163: Pfizer Inc. - Product / Service
Exhibit 164: Pfizer Inc. - Key news
Exhibit 165: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 166: Sanofi SA - Overview
Exhibit 167: Sanofi SA - Business segments
Exhibit 168: Sanofi SA - Key news
Exhibit 169: Sanofi SA - Key offerings
Exhibit 170: Sanofi SA - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 176: Inclusions checklist
Exhibit 177: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 178: Currency conversion rates for US$
13.4 Research methodology
Exhibit 179: Research methodology
Exhibit 180: Validation techniques employed for market sizing
Exhibit 181: Information sources
13.5 List of abbreviations
Exhibit 182: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global migraine drugs market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Retail - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Retail - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Type - Market share 2023-2028 (%)
Exhibits49: Data Table on Type - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Preventive - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Preventive - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Preventive - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Preventive - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Abortive - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Abortive - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Abortive - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Abortive - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Type ($ billion)
Exhibits61: Data Table on Market opportunity by Type ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: Amneal Pharmaceuticals Inc. - Overview
Exhibits119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits120: Amneal Pharmaceuticals Inc. - Key news
Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits123: AstraZeneca Plc - Overview
Exhibits124: AstraZeneca Plc - Product / Service
Exhibits125: AstraZeneca Plc - Key news
Exhibits126: AstraZeneca Plc - Key offerings
Exhibits127: Eli Lilly and Co. - Overview
Exhibits128: Eli Lilly and Co. - Product / Service
Exhibits129: Eli Lilly and Co. - Key news
Exhibits130: Eli Lilly and Co. - Key offerings
Exhibits131: Endo International Plc - Overview
Exhibits132: Endo International Plc - Business segments
Exhibits133: Endo International Plc - Key news
Exhibits134: Endo International Plc - Key offerings
Exhibits135: Endo International Plc - Segment focus
Exhibits136: GlaxoSmithKline Plc - Overview
Exhibits137: GlaxoSmithKline Plc - Business segments
Exhibits138: GlaxoSmithKline Plc - Key news
Exhibits139: GlaxoSmithKline Plc - Key offerings
Exhibits140: GlaxoSmithKline Plc - Segment focus
Exhibits141: H Lundbeck AS - Overview
Exhibits142: H Lundbeck AS - Product / Service
Exhibits143: H Lundbeck AS - Key offerings
Exhibits144: Johnson and Johnson - Overview
Exhibits145: Johnson and Johnson - Business segments
Exhibits146: Johnson and Johnson - Key news
Exhibits147: Johnson and Johnson - Key offerings
Exhibits148: Johnson and Johnson - Segment focus
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Otsuka Holdings Co. Ltd. - Overview
Exhibits159: Otsuka Holdings Co. Ltd. - Business segments
Exhibits160: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits161: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits162: Pfizer Inc. - Overview
Exhibits163: Pfizer Inc. - Product / Service
Exhibits164: Pfizer Inc. - Key news
Exhibits165: Pfizer Inc. - Key offerings
Exhibits166: Sanofi SA - Overview
Exhibits167: Sanofi SA - Business segments
Exhibits168: Sanofi SA - Key news
Exhibits169: Sanofi SA - Key offerings
Exhibits170: Sanofi SA - Segment focus
Exhibits171: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits172: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits173: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits174: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits175: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations

この商品のレポートナンバー

0000037291

TOP